These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3231507)

  • 1. Ceftriaxone and biliary pseudolithiasis.
    Billstein SA; Sudol TE
    Pediatr Infect Dis J; 1988 Nov; 7(11):818-20. PubMed ID: 3231507
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biliary pseudolithiasis due to ceftriaxone].
    García Alonso JA; Montejo Baranda M; de la Prieta López R; Aguirre Errasti C
    Med Clin (Barc); 1993 May; 100(17):677-8. PubMed ID: 8497180
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftriaxone-induced symptomatic pseudolithiasis mimicking ICP elevation.
    Evliyaoglu C; Kizartici T; Bademci G; Unal B; Keskil S
    Zentralbl Neurochir; 2005 May; 66(2):92-4. PubMed ID: 15846537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudolithiasis after recent use of ceftriaxone: an unexpected diagnosis in a child with abdominal pain.
    von Martels JZ; Van de Meeberg EK; Holman M; Ligtenberg JJ; Ter Maaten JC
    Am J Emerg Med; 2013 Aug; 31(8):1294.e5-6. PubMed ID: 23809091
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudolithiasis and intractable hiccups in a boy receiving ceftriaxone.
    Bonioli E; Bellini C; Tomà P
    N Engl J Med; 1994 Dec; 331(22):1532. PubMed ID: 7969321
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceftriaxone-associated biliary pseudolithiasis in children.
    Herek O; Pakdemirli E; Koçer N
    Eur Radiol; 2001; 11(5):902. PubMed ID: 11372630
    [No Abstract]   [Full Text] [Related]  

  • 18. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case report; a case of biliary pseudolithiasis associated with ceftriaxone].
    Hanata N; Imamura T; Koyama R; Koizumi Y; Tamura T; Ito J; Takeuch K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2955-7. PubMed ID: 23214106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.